Does Dr. Winton study skin cancer?

Yes, Dr. Winton focuses on preventing basal cell carcinoma, particularly in patients with a prior history of skin cancer.

What treatments has Dr. Winton researched?

He has researched isotretinoin, a medication commonly used for acne, to evaluate its potential in preventing new cases of skin cancer.

Is Dr. Winton's work relevant to patients with a history of skin cancer?

Absolutely, his research specifically targets individuals who have previously had skin cancer and are seeking effective prevention methods.

GEORGE BEVERLY WINTON, MD

JOHNSON CITY, TN

Research Active

Dermatology NPI registered 21+ years 2 publications 1990 – 2015 NPI: 1447253653

Dermatology Dermatology - MOHS-Micrographic Surgery Dermatology - Procedural Dermatology

Double-Blind Method Skin Neoplasms Research Design Mass Screening Postal Service Veterinary Service, Military Warfare Basal Cell Carcinoma Epidemiologic Methods Isotretinoin

Practice Location

1009 N STATE OF FRANKLIN ACCESS ROAD
JOHNSON CITY, TN 37604-3693

Phone: (423) 929-7546

What does GEORGE WINTON research?

Dr. Winton studies how certain medications can prevent skin cancer, specifically focusing on basal cell carcinoma, the most common type of skin cancer. His research involves using isotretinoin, a drug usually prescribed for severe acne, to see if it can help prevent new skin cancers in people who are at a higher risk due to their medical history. By examining a diverse group of participants aged between 40 and 75 who have had multiple skin cancers, he aims to provide insights into more effective prevention strategies for high-risk individuals.

Key findings

The trial involved nearly 1,000 participants with a history of skin cancers.
Participants were aged 40 to 75, all at high risk for developing new basal cell carcinoma.
The study aims to provide important data on the effectiveness and safety of low-dose isotretinoin for skin cancer prevention.

Frequently asked questions

Does Dr. Winton study skin cancer?: Yes, Dr. Winton focuses on preventing basal cell carcinoma, particularly in patients with a prior history of skin cancer.
What treatments has Dr. Winton researched?: He has researched isotretinoin, a medication commonly used for acne, to evaluate its potential in preventing new cases of skin cancer.
Is Dr. Winton's work relevant to patients with a history of skin cancer?: Absolutely, his research specifically targets individuals who have previously had skin cancer and are seeking effective prevention methods.

Publications in plain English

Postcards from the front.

2015

The Veterinary record

Winton G

PubMed

Isotretinoin-basal cell carcinoma prevention trial. Design, recruitment results, and baseline characteristics of the trial participants. The ISO-BCC Study Group.

1990

Controlled clinical trials

Tangrea J, Edwards B, Hartman A, Taylor P, Peck G +5 more

Plain English
The Isotretinoin-Basal Cell Carcinoma Prevention Trial studied whether a low dose of isotretinoin, a medication commonly used for acne, could prevent new cases of basal cell carcinoma in high-risk adults. Between 1984 and 1987, nearly 1,000 participants aged 40 to 75, all having previously had multiple skin cancers, were enrolled to assess the drug's effectiveness and any side effects. The findings will help understand how to better prevent skin cancer in individuals at high risk. Who this helps: This helps patients with a history of skin cancer looking for effective prevention methods.

PubMed

Frequent Co-Authors

J Tangrea B Edwards A Hartman P Taylor G Peck S Salasche P Menon R Mellette M Guill

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.